Integration-free induced pluripotent stem cells model genetic and neural developmental features of down syndrome etiology (Q50732745)

From Wikidata

Jump to navigation Jump to search

scientific article published in March 2013

Integration-Free Induced Pluripotent Stem Cells Model Genetic and Neural Developmental Features of Down Syndrome Etiology

Language	Label	Description	Also known as
English	Integration-free induced pluripotent stem cells model genetic and neural developmental features of down syndrome etiology	scientific article published in March 2013	Integration-Free Induced Pluripotent Stem Cells Model Genetic and Neural Developmental Features of Down Syndrome Etiology

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 March 2018

http://europepmc.org/abstract/MED/23225669

Integration-free induced pluripotent stem cells model genetic and neural developmental features of down syndrome etiology (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 March 2018

http://europepmc.org/abstract/MED/23225669

1 reference

based on heuristic

inferred from title

12

1 reference

Europe PubMed Central

PubMed publication ID

18 March 2018

http://europepmc.org/abstract/MED/23225669

Ernst Wolvetang

13

1 reference

Europe PubMed Central

PubMed publication ID

18 March 2018

http://europepmc.org/abstract/MED/23225669

object named as

Carl A Morrow

8

0 references

Dmitry A Ovchinnikov

object named as

Dmitry A Ovchinnikov

4

0 references

James Alexander Briggs

1

object named as

James A Briggs

1 reference

Europe PubMed Central

PubMed publication ID

18 March 2018

http://europepmc.org/abstract/MED/23225669

author name string

Jane Sun

2

1 reference

Europe PubMed Central

PubMed publication ID

18 March 2018

http://europepmc.org/abstract/MED/23225669

Jill Shepherd

3

1 reference

Europe PubMed Central

PubMed publication ID

18 March 2018

http://europepmc.org/abstract/MED/23225669

Tung-Liang Chung

5

1 reference

Europe PubMed Central

PubMed publication ID

18 March 2018

http://europepmc.org/abstract/MED/23225669

Sam P Nayler

6

1 reference

Europe PubMed Central

PubMed publication ID

18 March 2018

http://europepmc.org/abstract/MED/23225669

Li-Pin Kao

7

1 reference

Europe PubMed Central

PubMed publication ID

18 March 2018

http://europepmc.org/abstract/MED/23225669

Nilay Y Thakar

9

1 reference

Europe PubMed Central

PubMed publication ID

18 March 2018

http://europepmc.org/abstract/MED/23225669

Set-Yen Soo

10

1 reference

Europe PubMed Central

PubMed publication ID

18 March 2018

http://europepmc.org/abstract/MED/23225669

Teija Peura

11

1 reference

Europe PubMed Central

PubMed publication ID

18 March 2018

http://europepmc.org/abstract/MED/23225669

publication date

1 March 2013

1 reference

Europe PubMed Central

PubMed publication ID

18 March 2018

http://europepmc.org/abstract/MED/23225669

1 reference

Europe PubMed Central

PubMed publication ID

18 March 2018

http://europepmc.org/abstract/MED/23225669

31

1 reference

Europe PubMed Central

PubMed publication ID

18 March 2018

http://europepmc.org/abstract/MED/23225669

3

1 reference

Europe PubMed Central

PubMed publication ID

18 March 2018

http://europepmc.org/abstract/MED/23225669

467-478

1 reference

Europe PubMed Central

PubMed publication ID

18 March 2018

http://europepmc.org/abstract/MED/23225669

Updated national birth prevalence estimates for selected birth defects in the United States, 2004-2006

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1297

21 January 2018

The neuropsychology of Down syndrome: evidence for hippocampal dysfunction

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1297

21 January 2018

Behavioral phenotype of individuals with Down syndrome

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1297

21 January 2018

Understanding the basis for Down syndrome phenotypes

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1297

21 January 2018

Mental retardation and associated neurological dysfunctions in Down syndrome: a consequence of dysregulation in critical chromosome 21 genes and associated molecular pathways

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1297

21 January 2018

Dendritic atrophy in children with Down's syndrome

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1297

21 January 2018

Developmental changes of S-100 protein and glial fibrillary acidic protein in the brain in Down syndrome

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1297

21 January 2018

S100B and APP Promote a Gliocentric Shift and Impaired Neurogenesis in Down Syndrome Neural Progenitors

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1297

21 January 2018

Widespread proliferation impairment and hypocellularity in the cerebellum of fetuses with down syndrome.

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1297

21 January 2018

Cell cycle alteration and decreased cell proliferation in the hippocampal dentate gyrus and in the neocortical germinal matrix of fetuses with Down syndrome and in Ts65Dn mice

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1297

21 January 2018

Neurogenesis impairment and increased cell death reduce total neuron number in the hippocampal region of fetuses with Down syndrome.

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1297

21 January 2018

Apoptosis and increased generation of reactive oxygen species in Down's syndrome neurons in vitro.

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1297

21 January 2018

ets-2 promotes the activation of a mitochondrial death pathway in Down's syndrome neurons.

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1297

21 January 2018

The genetic architecture of Down syndrome phenotypes revealed by high-resolution analysis of human segmental trisomies

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1297

21 January 2018

Genotype-phenotype correlations in Down syndrome identified by array CGH in 30 cases of partial trisomy and partial monosomy chromosome 21

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1297

21 January 2018

Trisomy 21 and early brain development

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1297

21 January 2018

Down syndrome mouse models are looking up.

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1297

21 January 2018

Modelling brain diseases in mice: the challenges of design and analysis

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1297

21 January 2018

An aneuploid mouse strain carrying human chromosome 21 with Down syndrome phenotypes

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1297

21 January 2018

A mouse model of Down syndrome trisomic for all human chromosome 21 syntenic regions

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1297

21 January 2018

Mouse models of Down syndrome: how useful can they be? Comparison of the gene content of human chromosome 21 with orthologous mouse genomic regions

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1297

21 January 2018

Investigating monogenic and complex diseases with pluripotent stem cells

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1297

21 January 2018

Basic FGF and suppression of BMP signaling sustain undifferentiated proliferation of human ES cells

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1297

21 January 2018

Human induced pluripotent stem cells free of vector and transgene sequences

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1297

21 January 2018

Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1297

21 January 2018

Robust enhancement of neural differentiation from human ES and iPS cells regardless of their innate difference in differentiation propensity

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1297

21 January 2018

Transcriptional analysis of early lineage commitment in human embryonic stem cells

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1297

21 January 2018

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1297

21 January 2018

Galaxy: a web-based genome analysis tool for experimentalists

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1297

21 January 2018

Galaxy: a comprehensive approach for supporting accessible, reproducible, and transparent computational research in the life sciences

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1297

21 January 2018

Normalization of cDNA microarray data

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1297

21 January 2018

Global up-regulation of chromosome 21 gene expression in the developing down syndrome brain

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1297

21 January 2018

Primary and secondary transcriptional effects in the developing human Down syndrome brain and heart

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1297

21 January 2018

Gene expression profiling in the adult Down syndrome brain.

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1297

21 January 2018

Classification of human chromosome 21 gene-expression variations in Down syndrome: impact on disease phenotypes

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1297

21 January 2018

The cerebellar transcriptome during postnatal development of the Ts1Cje mouse, a segmental trisomy model for Down syndrome.

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1297

21 January 2018

Global disruption of the cerebellar transcriptome in a Down syndrome mouse model

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1297

21 January 2018

Transcript level alterations reflect gene dosage effects across multiple tissues in a mouse model of down syndrome

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1297

21 January 2018

A critical period in cortical interneuron neurogenesis in down syndrome revealed by human neural progenitor cells.

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1297

21 January 2018

Timing is everything: making neurons versus glia in the developing cortex

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1297

21 January 2018

Overexpression of the chromosome 21 transcription factor Ets2 induces neuronal apoptosis.

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1297

21 January 2018

ETS2 overexpression in transgenic models and in Down syndrome predisposes to apoptosis via the p53 pathway

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1297

21 January 2018

Identifiers

10.1002/STEM.1297

1 reference

Europe PubMed Central

PubMed publication ID

18 March 2018

http://europepmc.org/abstract/MED/23225669

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 March 2018

http://europepmc.org/abstract/MED/23225669

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50732745&oldid=2260424024"